Page last updated: 2024-12-07

tryptoquivaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tryptoquivaline is a fungal metabolite produced by the Aspergillus genus. It is a potent inhibitor of protein biosynthesis, specifically targeting the peptidyl transferase center of the ribosome. Tryptoquivaline exhibits a unique structure characterized by a fused indole-pyrrole ring system. Its biosynthesis is thought to involve a complex pathway involving tryptophan and a polyketide precursor. The compound's potent biological activity has led to significant research interest in its potential as a pharmacological tool for studying protein synthesis and its role in various cellular processes. Notably, tryptoquivaline's ability to inhibit protein synthesis has implications for its potential as an antifungal agent, although its toxicity limits its clinical applications. Research into tryptoquivaline focuses on understanding its mechanism of action, exploring its potential therapeutic applications, and investigating its role in fungal biology.'

fumitremorgin C : An organic heteropentacyclic compound that is a mycotoxic indole alkaloid produced by several fungi. A potent and specific inhibitor of the breast cancer resistance protein multidrug transporter. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

tryptoquivaline: tremor-producing metabolite from Aspergillus clavatus; tetrapeptide derived from tryptophan, anthranilic acid, valine, & methylalanine; structure & N1 names previously assigned to tryptoquivaline C & tryptoquivaline D found to be incorrect & are revised in third source; see also record for tryptoquivalone; structure in third source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID403923
CHEMBL ID410316
CHEBI ID72763
SCHEMBL ID13113871
MeSH IDM0056065
PubMed CID108075
CHEMBL ID2386536
MeSH IDM0056065

Synonyms (47)

Synonym
nsc719655
fumitremorgin c
NCI60_041052
fumitremorgin c, from neosartorya fischeri, >98% (hplc and tlc), film
118974-02-0
nsc-719655
bdbm32628
chebi:72763 ,
CHEMBL410316
(5as,12s,14as)-9-methoxy-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5h,14h-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14-dione
MLS004257389
smr003082520
C20604
DBEYVIGIPJSTOR-FHWLQOOXSA-N
fumitremorgin-c
(5as,12s,14as)-1,2,3,5a,6,11,12,14a-octahydro-9-methoxy-12-(2-methyl-1-propen-1-yl)-5h,14h-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14-dione
SCHEMBL13113871
HB3071
AKOS024457321
DTXSID10328045
(1s,12s,15s)-7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0^{3,11}.0^{4,9}.0^{15,19}]icosa-3(11),4,6,8-tetraene-14,20-dione
J-003995
HY-N2143
CS-6844
(1s,12s,15s)-7-methoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione
sm-q
Q27140130
gtpl10008
12a-fumitremorgin c
F85534
12-fumitremorgin c
nsc 719655
BF162727
tryptoquivaline
55387-45-6
[(1s)-1-[3-[(3'r,3as,4s)-3-hydroxy-2,2-dimethyl-1,2'-dioxospiro[3ah-imidazo[1,2-a]indole-4,5'-oxolane]-3'-yl]-4-oxoquinazolin-2-yl]-2-methylpropyl] acetate
CHEMBL2386536
(9'r-(9'alpha(4s*(r*)),9'abeta))-4-(2-(1-(acetyloxy)-2-methylpropyl)-4-oxo-3(4h)-quinazolinyl)-1',3,4,9'a-tetrahydro-1'-hydroxy-2',2'-dimethylspiro(furan-2(5h),9'-(9h)imidazo(1,2-a) indole)-3',5(2'h)-dione
unii-cw5s8op3vo
cw5s8op3vo ,
spiro(furan-2(5h),9'-(9h)imidazo(1,2-a)indole)-3',5(2'h)-dione, 4-(2-((1s)-1-(acetyloxy)-2-methylpropyl)-4-oxo-3(4h)-quinazolinyl)-1',3,4,9'a-tetrahydro-1'-hydroxy-2',2'-dimethyl-, (2s,4r,9'as)-
spiro(furan-2(5h),9'-(9h)imidazo(1,2-a)indole)-3',5(2'h)-dione, 4-(2-(1-(acetyloxy)-2-methylpropyl)-4-oxo-3(4h)-quinazolinyl)-1',3,4,9'a-tetrahydro-1'-hydroxy-2',2'-dimethyl-, (9's-(9'.alpha.(4s*(r*)),9'a.beta.))-
tryptoquivaline c
tryptoquivaline a
1-[3-(1-hydroxy-2,2-dimethyl-3,5'-dioxo-1,2,3,9a-tetrahydrospiro[imidazo[1,2-a]indole-9,2'-oxolan]-4'-yl)-4-oxo-3,4-dihydroquinazolin-2-yl]-2-methylpropyl acetate
DTXSID90970728
Q27275854

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Highly expressed in placental syncytiotrophoblasts, brain microvasculature, and the gastrointestinal tract, ABCG2 has been shown to mediate normal tissue protection as well as limit oral bioavailability of substrate compounds."( Botryllamides: natural product inhibitors of ABCG2.
Ambudkar, SV; Bates, SE; Bokesch, HR; Gustafson, KR; Henrich, CJ; McMahon, JB; Robey, RW; Shukla, S; Takada, K, 2009
)
0.35
" It has been demonstrated that the ATP-binding cassette (ABC) transporter P-glycoprotein (P-gp/ABCB1) is a key determinant of oral bioavailability of HIV-1 protease inhibitors and their penetration of the central nervous system."( The role of breast cancer resistance protein (BCRP/ABCG2) in cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
Baba, M; Wang, X, 2005
)
0.33

Dosage Studied

ExcerptRelevanceReference
" The effects of P-glycoprotein (P-gp), multidrug resistance-associated protein 2 (MRP2), and breast cancer resistance protein (BCRP) inhibitors on sulfasalazine bidirectional permeability were studied across Caco-2 cell monolayers, including dose-response analysis."( Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Amidon, GL; Dahan, A, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
mycotoxinPoisonous substance produced by fungi.
breast cancer resistance protein inhibitorAny inhibitor of breast cancer resistance protein (ABCG2).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
indole alkaloidAn alkaloid containing an indole skeleton.
organic heteropentacyclic compound
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
fumitremorgin C biosynthesis518
fumitremorgin A biosynthesis412
superpathway of fumitremorgin biosynthesis925

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-dependent translocase ABCB1Homo sapiens (human)IC50 (µMol)1.80800.00022.318510.0000AID1690381
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)IC50 (µMol)1.58990.00401.966610.0000AID1277333; AID1320723; AID1385908; AID1464384; AID1464398; AID1464399; AID1690372; AID1799218; AID1873200; AID370449; AID587298; AID734837
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)Ki1.30000.50000.90001.3000AID679625
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-dependent translocase ABCB1Homo sapiens (human)EC50 (µMol)0.41200.01600.67863.1000AID1690379
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)EC50 (µMol)1.00000.00540.42203.2000AID1525951
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (26)

Processvia Protein(s)Taxonomy
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
lipid transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid biosynthetic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate metabolic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transmembrane transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transepithelial transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
renal urate salt excretionBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
export across plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
cellular detoxificationBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ABC-type xenobiotic transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
efflux transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP hydrolysis activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATPase-coupled transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
identical protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
protein homodimerization activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
nucleoplasmBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
brush border membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrial membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
membrane raftBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
external side of apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (85)

Assay IDTitleYearJournalArticle
AID627480Inhibition of ATP-dependent ABCG2 pump assessed as ratio of mitoxantrone IC50 for HEK/ABCG2-482-R2 cells to mitoxantrone IC50 for HEK293/pcDNA3.1 cells in presence of 2.5 uM of drug after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Inhibition of c-Kit, VEGFR-2 (KDR), and ABCG2 by analogues of OSI-930.
AID537736Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1336110Inhibition of BCRP in human K562 cells assessed as potentiation of SN38-mediated growth inhibition at 3 uM after 4 days by coulter counter method2016Bioorganic & medicinal chemistry letters, 12-15, Volume: 26, Issue:24
Biosynthetic approaches to creating bioactive fungal metabolites: Pathway engineering and activation of secondary metabolism.
AID679172TP_TRANSPORTER: drug resistance in BCRP-expressing LLC-PK1 cells2003Molecular pharmacology, Sep, Volume: 64, Issue:3
Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
AID492325Inhibition of MRP1 expressed in human A2780 cells at 10 uM relative to control2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
AID1328174Inhibition of human ABCG2 R482 mutant transfected in HEK293 cells assessed as potentiation of mitoxantrone-induced cytotoxicity by measuring mitoxantrone IC50 at 3000 nM after 72 hrs by CCK8 assay (Rvb = 107.40 +/- 13.93 nM)2016Journal of natural products, 08-26, Volume: 79, Issue:8
Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.
AID734836Inhibition of ABCG2 in human MCF7/Topo cells at 70 to 100 uM after 2 hrs by Hoechst 33342 microplate assay relative to 10 uM fumitremorgin2013ACS medicinal chemistry letters, Apr-11, Volume: 4, Issue:4
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.
AID1555763Inhibition of BCRP-mediated mitoxantrone efflux in human NCI-H460/MX20 cells assessed as mitoxantrone accumulation at 10 uM after 15 mins by Hoechst 33342 staining based flow cytometry analysis relative to control2019European journal of medicinal chemistry, Aug-15, Volume: 176Natural products as multidrug resistance modulators in cancer.
AID1690379Activation of ABCB1 ATPase activity (unknown origin) expressed in baculovirus infected Sf9 insect cells using ATP as substrate measured after 1 hr by colorimetric assay2020European journal of medicinal chemistry, Apr-01, Volume: 191Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).
AID423398Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID282897Cytotoxicity against mitoxantrone-sensitive human HCT116 cells at 10 uM assessed as viable cells after 48 hrs2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).
AID282895Inhibition of BCRP expressed in mitoxantrone-resistant human HCT116 cells assessed as increase in mitoxantrone accumulation at 10 uM after 15 mins2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).
AID1336111Inhibition of BCRP (unknown origin)-dependent ATPase activity at 50 uM after 30 mins by malachite green method2016Bioorganic & medicinal chemistry letters, 12-15, Volume: 26, Issue:24
Biosynthetic approaches to creating bioactive fungal metabolites: Pathway engineering and activation of secondary metabolism.
AID492324Inhibition of Pgp expressed in mouse L5178Y cells at 10 uM relative to control2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
AID1277333Inhibition of ABCG2 in human MCF7/Topo cells by Hoechst 33342 assay2016European journal of medicinal chemistry, Feb-15, Volume: 109Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.
AID1690381Inhibition of sulfasalazine-stimulated ABCB1 ATPase activity (unknown origin) expressed in baculovirus infected Sf9 insect cells using ATP as substrate measured after 1 hr by colorimetric assay2020European journal of medicinal chemistry, Apr-01, Volume: 191Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).
AID1082824Antifeedant activity against Mythimna separata (Oriental armyworm) larvae assessed as antifeedant index by area of the leaf consumed2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID537734Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID370449Inhibition of ABCG2 overexpressed in human MCF7/Topo cells by flow cytometric-based mitoxantrone efflux assay2009Journal of medicinal chemistry, Feb-26, Volume: 52, Issue:4
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
AID678965TP_TRANSPORTER: drug resistance in BCRP-expressing PA317 cells2003International journal of cancer, Dec-10, Volume: 107, Issue:5
Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.
AID1277331Inhibition of human MRP1 transfected in MDCK2 cells assessed as inhibition of calcein-AM efflux2016European journal of medicinal chemistry, Feb-15, Volume: 109Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.
AID627482Inhibition of ATP-dependent ABCG2 pump assessed as ratio of mitoxantrone IC50 for HEK293/pcDNA3.1 cells to mitoxantrone IC50 for HEK293/pcDNA3.1 cells in presence of 2.5 uM of drug after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Inhibition of c-Kit, VEGFR-2 (KDR), and ABCG2 by analogues of OSI-930.
AID1464397Potentiation of mitoxantrone induced antiproliferative activity against human H460 cells assessed as mitoxantrone IC50 at 1 uM preincubated for 2 hrs followed by mitoxantrone addition measured after 72 hrs by MTT assay (Rvb = 0.215 +/- 0.011 microM)2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID1464385Resistance index, ratio of mitoxantrone IC50 for human H460/MX20 cells to mitoxantrone IC50 for human H460 cells at 10 uM (Rvb = 28.66 No_unit)2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID1082819Antifungal activity against Fusarium solani at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID423397Cytotoxicity against human K562 cells after 48 hrs by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID537733Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID370720Inhibition of ABCC2 overexpressed in MDCK cells at 100 uM up to 50 uM by flow cytometric-based chloromethylfluorescein-diacetate accumulation assay2009Journal of medicinal chemistry, Feb-26, Volume: 52, Issue:4
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
AID1464387Resistance index, ratio of mitoxantrone IC50 for human H460/MX20 cells to mitoxantrone IC50 for human H460 cells at 1 uM (Rvb = 28.66 No_unit)2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID587298Inhibition of ABCG2 expressed in human NCI-H460 cells assessed as inhibition of PhA accumulation after 2 to 20 hrs relative to fumitremorgin C2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Flavonoids from eight tropical plant species that inhibit the multidrug resistance transporter ABCG2.
AID680988TP_TRANSPORTER: inhibition of MTX in membrane vesicles from BCRP-expressing MCF7 cells2003Cancer research, Sep-01, Volume: 63, Issue:17
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
AID1328172Potentiation of mitoxantrone-induced cytotoxicity against HEK293 cells assessed as mitoxantrone IC50 at 3000 nM after 72 hrs by CCK8 assay (Rvb = 1 +/- 0.19 nM)2016Journal of natural products, 08-26, Volume: 79, Issue:8
Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.
AID1320723Inhibition of BCRP in human MCF7/Topo cells assessed as mitoxantrone accumulation preincubated for 10 mins followed by mitoxantrone addition measured after 30 mins by fluorescence assay2016Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
Halogenated naphthochalcones and structurally related naphthopyrazolines with antitumor activity.
AID1690372Inhibition of ABCG2 in topotecan-cultured human MCF7 cells using Hoechst 33342 as substrate measured after 2 hrs by fluorescence assay2020European journal of medicinal chemistry, Apr-01, Volume: 191Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).
AID1082815Antifungal activity against Botryotinia fuckeliana at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID1082823Toxicity in Artemia salina (brine shrimp) at 28 degC after 48 hr2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID423399Induction of neurite outgrowth in rat PC12 cells at 10 uM after 2 days by phase-contrast microscope2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID1464384Inhibition of ABCG2 in human H460/MX20 cells assessed as potentiation of mitoxantrone induced antiproliferative activity by measuring mitoxantrone IC50 at 10 uM preincubated for 2 hrs followed by mitoxantrone addition measured after 72 hrs by MTT assay (R2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID1328176Inhibition of human ABCG2 R482 mutant transfected in HEK293 cells assessed as potentiation of mitoxantrone-induced cytotoxicity by measuring mitoxantrone resistance ratio at 3000 nM after 72 hrs by CCK8 assay relative to parental HEK293 cells (Rvb = 107 N2016Journal of natural products, 08-26, Volume: 79, Issue:8
Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.
AID1082816Antifungal activity against Alternaria solani at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID1464398Inhibition of ABCG2 in human H460/MX20 cells assessed as potentiation of mitoxantrone induced antiproliferative activity by measuring mitoxantrone IC50 at 3 uM preincubated for 2 hrs followed by mitoxantrone addition measured after 72 hrs by MTT assay (Rv2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID679625TP_TRANSPORTER: inhibition of ATPase in membrane vesicle from BCRP-expressing Sf9 cells2001Biochemical and biophysical research communications, Jul-06, Volume: 285, Issue:1
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
AID423396Cytotoxicity against human KB cells after 48 hrs by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID1082818Antifungal activity against Colletotrichum gloeosporioides at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID1464396Potentiation of mitoxantrone induced antiproliferative activity against human H460 cells assessed as mitoxantrone IC50 at 3 uM preincubated for 2 hrs followed by mitoxantrone addition measured after 72 hrs by MTT assay (Rvb = 0.215 +/- 0.011 microM)2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID1873200Inhibition of human ABCG2 expressed in dog MDCK-II-BCRP cells mediated pheophorbide A efflux preincubated with PhA followed by compound addition and measured after 60 mins by flow cytometry2022European journal of medicinal chemistry, Jul-05, Volume: 237Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
AID1082821Antifungal activity against Fusarium oxysporum f. sp. vasinfectum at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID322371Inhibition of human BCRP mediated mitoxantrone accumulation in mitoxantrone resistant MCF7 cells at 10 uM by flow cytometry2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein.
AID492326Inhibition of MRP2 expressed in human A2780 cells at 10 uM relative to control2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
AID1690380Activation of ABCB1 ATPase activity (unknown origin) expressed in baculovirus infected Sf9 insect cells using ATP as substrate measured after 1 hr by colorimetric assay relative to sulfasalazine2020European journal of medicinal chemistry, Apr-01, Volume: 191Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).
AID537735Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1082817Antifungal activity against Alternaria alternata at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID734837Inhibition of ABCG2 in human MCF7/Topo cells after 2 hrs by Hoechst 33342 microplate assay2013ACS medicinal chemistry letters, Apr-11, Volume: 4, Issue:4
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.
AID492328Inhibition of BCRP expressed in human EPG-257RNOV cells at 1 uM relative to control2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
AID1082820Antifungal activity against Fusarium oxysporum f. sp. niveum at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID681189TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 20 uM, FTC: 50 uM) in BCRP-expressing NCI-H460 cells2004Molecular pharmacology, May, Volume: 65, Issue:5
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
AID1525951Inhibition of BCRP (unknown origin)2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors.
AID680319TP_TRANSPORTER: efflux of 3uM mitoxantrone by Fumitremorgin C at 10uM in MCF7/R cells2004Cancer chemotherapy and pharmacology, May, Volume: 53, Issue:5
Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023.
AID370718Inhibition of ABCB1 overexpressed in human KBv1 cells at 100 uM by flow cytometric-based calcein-AM efflux assay2009Journal of medicinal chemistry, Feb-26, Volume: 52, Issue:4
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
AID1690377Inhibition of human ABCC1 transfected in MDCK2-MRP1 cells up to 100 uM using calcein-AM as substrate measured after 1 hr by fluorescence assay relative to control2020European journal of medicinal chemistry, Apr-01, Volume: 191Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).
AID1464383Potentiation of mitoxantrone induced antiproliferative activity against human H460 cells assessed as mitoxantrone IC50 at 10 uM preincubated for 2 hrs followed by mitoxantrone addition measured after 72 hrs by MTT assay (Rvb = 0.215 +/- 0.011 microM)2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID370450Inhibition of ABCG2 over-expressed in human MCF7/Topo cells at 7 to 10 uM by flow cytometric-based mitoxantrone efflux assay relative to fumitremorgin C2009Journal of medicinal chemistry, Feb-26, Volume: 52, Issue:4
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
AID1464386Resistance index, ratio of mitoxantrone IC50 for human H460/MX20 cells to mitoxantrone IC50 for human H460 cells at 3 uM (Rvb = 28.66 No_unit)2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID1690374Inhibition of ABCB1 in human KB-V1 cells using calcein-AM as substrate measured after 10 mins by fluorescence assay2020European journal of medicinal chemistry, Apr-01, Volume: 191Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).
AID1082822Antifungal activity against Fusarium graminearum at 28 degC after 48 hr microbroth dilution method2012Journal of agricultural and food chemistry, Apr-04, Volume: 60, Issue:13
Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
AID492327Inhibition of BCRP expressed in human EPG-257RNOV cells at 0.1 uM relative to control2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
AID1277332Inhibition of ABCB1 in human KBV1 cells assessed as inhibition of calcein-AM efflux2016European journal of medicinal chemistry, Feb-15, Volume: 109Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.
AID1385908Inhibition of ABCG2 in human MCF7/Topo cells after 2 hrs by Hoechst 33342 staining based fluorescence assay2018ACS medicinal chemistry letters, Aug-09, Volume: 9, Issue:8
Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators.
AID1464399Inhibition of ABCG2 in human H460/MX20 cells assessed as potentiation of mitoxantrone induced antiproliferative activity by measuring mitoxantrone IC50 at 1 uM preincubated for 2 hrs followed by mitoxantrone addition measured after 72 hrs by MTT assay (Rv2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
AID492323Inhibition of Pgp expressed in mouse L5178Y cells at 1 uM relative to control2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
AID370717Inhibition of ABCB1 overexpressed in human KBv1 cells at 10 uM by flow cytometric-based calcein-AM efflux assay2009Journal of medicinal chemistry, Feb-26, Volume: 52, Issue:4
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
AID681203TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 100 uM, FTC: 50 uM) in BCRP-expressing MCF-7 cells2004Molecular pharmacology, May, Volume: 65, Issue:5
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
AID734840Inhibition of ABCB1 in human KBV1 cells after 10 mins by Calcein-AM microplate assay2013ACS medicinal chemistry letters, Apr-11, Volume: 4, Issue:4
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.
AID588994Inhibitors of transporters of clinical importance in the absorption and disposition of drugs, BCRP2010Nature reviews. Drug discovery, Mar, Volume: 9, Issue:3
Membrane transporters in drug development.
AID664587Cytotoxicity against human MCF7 cells assessed as suppression of SP-positive cells at 10 uM after 90 mins by Hoechst staining-based FACS analysis (Rvb = 2.71%)2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Asperjinone, a nor-neolignan, and terrein, a suppressor of ABCG2-expressing breast cancer cells, from thermophilic Aspergillus terreus.
AID1799218Screening Assay for ABCG2 Inhibitors from Article 10.1021/cb900134c: \\Botryllamides: Natural Product Inhibitors of ABCG2.\\2009ACS chemical biology, Aug-21, Volume: 4, Issue:8
Botryllamides: natural product inhibitors of ABCG2.
AID1617929Antibacterial activity against Bacillus subtilis after 24 hrs by two fold dilution assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
AID1617925Antiproliferative activity against human HeLa cells after 24 to 72 hrs by MTT assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
AID1617930Antibacterial activity against Streptococcus agalactiae after 24 hrs by two fold dilution assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
AID1617932Antiproliferative activity against human K562 cells after 24 to 72 hrs by MTT assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
AID751219Antiviral activity against Influenza A virus H1N1 infected in dog MDCK cells after 48 hrs by CPE inhibition assay2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Antiviral alkaloids produced by the mangrove-derived fungus Cladosporium sp. PJX-41.
AID1617928Antibacterial activity against Escherichia coli after 24 hrs by two fold dilution assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
AID1617924Antiproliferative activity against human SGC7901 cells after 24 to 72 hrs by MTT assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
AID1617927Antibacterial activity against Staphylococcus aureus after 24 hrs by two fold dilution assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
AID1617926Antiproliferative activity against human A549 cells after 24 to 72 hrs by MTT assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (107)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (3.74)18.7374
1990's3 (2.80)18.2507
2000's50 (46.73)29.6817
2010's46 (42.99)24.3611
2020's4 (3.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.04 (24.57)
Research Supply Index4.43 (2.92)
Research Growth Index5.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews4 (13.79%)6.00%
Reviews4 (4.82%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other25 (86.21%)84.16%
Other79 (95.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]